RTW Biotech Opportunities (RTW:138¢) is a specialist healthcare investor in innovative biotech and medtech companies. The closed-end fund has been successful, generating an annualised 10.1 per cent ...

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...